Why Cineplex (TSX:CGX) Stock Remains a Risky Investment

The theatre chain operator stock Cineplex (TSX:CGX) has soared almost 200% since the vaccine launch in October last year.

| More on:
movies, theatre, popcorn

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Vaccine-related news and post-pandemic recovery hopes have notably boosted re-opening plays since last year. Re-opening stocks have soared almost 110%, while TSX stocks at large are up just 30% in the last 12 months. One of the popular names among them is Cineplex (TSX:CGX). The theatre chain operator stock has soared almost 200% since the vaccine launch in October last year. But will it continue to delight investors in the long term?

Cineplex: Q1 2021 earnings

Cineplex reported its Q1 2021 earnings much on the expected lines. Its revenues during the quarter came in at $33 million — a sizeable drop of 85% year over year. This was the fourth consecutive quarter for the company where its top line fell by more than 85% or more. Cineplex posted a net loss of $89.7 million for the quarter ended March 2021.

However, the worst part is not its revenues or earnings dent. The bigger concern is its fast-deteriorating liquidity position. With mobility restrictions and closures in place, Cineplex is bleeding cash at a rapid pace. It burnt $80.5 million cash in Q1 2021, the highest since last year, compared to $74.3 million in Q4 2020. Notably, the company had a cash balance of a mere $19.5 million at the end of March 2021.

Cineplex has done a flurry of remedies to plug its cash spill in the last few months, from dividend suspensions to selling and leasing back its head office building. However, none of the cures have worked meaningfully, and its liquidity position has worsened.

Risks and challenges

Investors should note that things have not changed in Q2 2021 on the restrictions front. So, one can expect another quarter of financial dent and cash burn from Cineplex. In the last 12 months, it has booked $540 million in net loss, which is equivalent to previous six years of profits.

Faster vaccinations and a gradual release of restrictions could change the fate of Cineplex, though. The footfall should gradually increase and will help the company lower its cash burn.

However, the positive impact of this will likely be slower and lesser in magnitude. That’s because even if a majority of the population gets vaccinated, the speed at which it can increase foot traffic in theatres will be interesting to see.

Besides, the pandemic has changed consumer behaviour significantly, which seems unlikely to reverse anytime soon. For the last more than a year, people staying at home are more used to watch movies on the OTT platforms, which could continue post-pandemic.

Valuation

Some analysts claim Cineplex as a value pick. However, the stock is currently trading at a price-to-book value ratio of 34, notably higher than its historical average.

Deteriorating liquidity position must be forcing Cineplex to raise additional capital at higher interest rates. This will likely push its profitability further, ultimately impacting shareholder returns.

I think CGX stock might trade volatile in the short term with limited upside potential. If reopening efforts stall, its balance sheet should weaken further. Meanwhile, the company might have to look for additional avenues to lower its cash burn to survive longer.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vineet Kulkarni has no position in any of the stocks mentioned. The Motley Fool recommends CINEPLEX INC.

More on Dividend Stocks

edit Person using calculator next to charts and graphs
Dividend Stocks

The 3 Best Dividend Stocks for Monthly Passive Income

These three dividend stocks are the best options for those seeking high passive income in the next few years in…

Read more »

clock time
Dividend Stocks

Got $10,000 to Invest? 1 Cheap TSX Stock to Buy Right Now

This top TSX dividend stock is finally on sale and has made some savvy buy-and-hold investors quite rich.

Read more »

A close up image of Canadian $20 Dollar bills
Dividend Stocks

Want Monthly Passive Income? These TSX Dividend Stocks Are for You

If you want monthly passive income from TSX stocks, you have to do a little digging. I've given you a…

Read more »

ETF chart stocks
Dividend Stocks

3 International ETFs to Buy for a Diversified Portfolio

Some international markets may prove more resilient against economic downturns, and exposure to them may strengthen your portfolio during crashes…

Read more »

Payday ringed on a calendar
Dividend Stocks

TFSA Pension: 3 Canadian Dividend Stocks to Buy for Monthly Passive Income

These high-yield Canadian stocks look good to buy right now for a TFSA focused on monthly passive income.

Read more »

TIMER SAYING TIME FOR ACTION
Dividend Stocks

Need $500 Right Away? These 3 Passive-Income Stocks Have Got You Covered

I could really use an extra $500 to feed my kids, who seem to be permanently hungry. Couldn't you?

Read more »

Young adult woman walking up the stairs with sun sport background
Dividend Stocks

3 Top TSX Stocks to Begin Your Investment Journey

Given their solid business models and stable cash flows, these three TSX stocks are ideal for income-seeking investors.

Read more »

Community homes
Dividend Stocks

Housing Market Crash: How to Make a Profit 

The housing market crash is here, but you can still earn dividends with Brookfield Infrastructure Partners (TSX:BIP.UN)(NYSE:BIP).

Read more »